Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (8717)	5/30/1998 12:20:00 PM
From: Perry	Read Replies (2) \| Respond to of 23519

VLAD, Viagra shouldn't be your concern, or any other VVUS investor's concern, but rather all the new drugs coming on the market in the next few years (e.g. ICOS etc...) that will squeeze Muse right out. PFE and Viagra will hold its own against competitors and the stock will continue to be strong based on their pipeline. I would take a close look at VVUS and question your holdings in this company. Perry

To: VLAD who wrote (8717)	5/30/1998 2:36:00 PM
From: DaiS	Read Replies (2) \| Respond to of 23519

Vlad, I think Perry is one of those from the PFE thread with an "attitude" problem, spouting "in the face" remarks. They must be getting uneasy there. I'm not sure now whether I regret buying PFE as well as Vivus. My stocks and shares primer than I have been studying for the last few weeks marks PFE as a bad buy. No matter how optimistic I am with the viagra sales and EPS growth rates, I can't get the P/E ratio down enough. If PFE goes to my entry point - 114 - I think I might sell. DaiS